Our results on FGF19-dependent activation of growth-related pathways in the liver are in agreement with previous reports, showing that Fgf15-/- mice develop less hepatocellular carcinoma as compared to Fgf15+/+ littermates [55], and display impaired liver regeneration [56]. Here, FGF19 is linked to hepatocellular carcinoma.